Research Center Profile | Tulsa OK Ear, Nose & Throat Doctor | Vital Prospects Clinical Research Institute, P.C.

Latest News | Photo Gallery | Member log in

Home

Patients

Home > Research

Research

Vital Prospects Clinical Research Institute, P.C.

We are a dedicated research center. Founded in 2007, we have become a premier multidisciplinary research center for the state of Oklahoma. We are committed to promoting patient care through the research of innovative therapies. We serve as an educational resource for the patient as well as health care professionals. We have many current ongoing and/or open enrollment in multiple therapeutic trials. Contact us and/or visit this website for more information.

ASTERIA A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) Sponsored by Genentech

HIVES - CHRONIC IDIOPATHIC URTICARIA (CIU) - A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Trea

Male or Female 12-75 years old and able to give assent, consent or obtain parental consent (parent of minors must be present)
History of Chronic Idiopathic Urticaria (CIU) (Hives) for at least 3 months
History of H1 antihystamine use with unresponsive results

MORE INFO CONTACT INFO

Clinical Study to Assess the Efficacy and Safety of DF289 plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients with ear tubes.

Acute Otitis Media With Tubes (Ear Infection)

6 months to 12 years
ear tube in the ear which will be treated
otorrhea for 3 weeks or less
moderate or severe otorrhea

MORE INFO CONTACT INFO

GSK Summit HZC113782 COPD clinical outcomes study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder with placebo on survivial in subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increa

Chronic Obstructive Pulmonary Disease (COPD)

MORE INFO CONTACT INFO

PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Sponsored by National Heart, Lung, and Blood Institute (NHLBI)with Duke Clinical Research Institute

New Chest Pain Presentation A prospective multicenter imaging study for evaluation of chest pain. Objective is to determine whether an initial non-invasive anatomic imaging strategy with coronary CT angiography (CTA) will improve clinical outcomes in sub

Men and women 45-65 years old and willing to give consent
New or worsening chest pain suspicious for clinical significant CAD
No prior evaluation for this episode of symptoms
Planned non-invasive testing for diagnosis

MORE INFO CONTACT INFO

Therapeutic Areas

Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Hematology
Immunology/Infectious Diseases
Ophthalmology
Otolaryngology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology

Featured Testimonials

2010-05-27
I met Dr. Husain and his research professional team at the Saint Frances Wellness Health Fair held in the Saint Frances Wellness facility on January 2010.
Linda Shoemaker

Please click here or on Centerwatch logo to see our research Center profile.

ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world.

Please click here to see more information.